While the share price declined over five years, Becton Dickinson actually managed to increase EPS by an average of 14% per year. So it doesn't seem like EPS is a great guide to understanding how the ...

Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the shares. The firm says its 2025 medical technology outlook ...

Headquartered in Franklin Lakes, New Jersey, Becton, Dickinson and Company (BDX) is a global leader in medical technology dedicated to advancing healthcare. With a market cap of $64.5 billion, BD ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its price target lowered by Barclays from $279.00 to $261.00 in a report issued on Monday,Benzinga reports. The firm currently has an ...

Becton Dickinson has paid out a dividend consecutively for the last 23 years. Becton Dickinson maintains a beta of 0.85, lower than the average company. Becton Dickinson issued its earnings data on ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting results this Thursday before market ...

The Style Scores are broken down into four categories: Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value ... Based in ...

Fiduciary Management Inc. (FMI), an independent money management firm, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Stock markets rallied in the third ...

Capital Investment Advisors LLC lowered its holdings in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 26.0% in the second quarter, HoldingsChannel reports. The firm owned 1,503 shares of ...